These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11738349)

  • 21. Synthesis and biological evaluation of coumarin derivatives as inhibitors of Mycobacterium bovis (BCG).
    Rezayan AH; Azerang P; Sardari S; Sarvary A
    Chem Biol Drug Des; 2012 Dec; 80(6):929-36. PubMed ID: 22943459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel screening method based on menadione mediated rapid reduction of tetrazolium salt for testing of anti-mycobacterial agents.
    Singh U; Akhtar S; Mishra A; Sarkar D
    J Microbiol Methods; 2011 Feb; 84(2):202-7. PubMed ID: 21129420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antituberculous drug susceptibility testing of Mycobacterium bovis BCG strain Montréal.
    Rousseau P; Dupuis M
    Can J Microbiol; 1990 Oct; 36(10):735-7. PubMed ID: 2253115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Three antimycobacterial metabolites identified from a marine-derived Streptomyces sp. MS100061.
    Chen C; Wang J; Guo H; Hou W; Yang N; Ren B; Liu M; Dai H; Liu X; Song F; Zhang L
    Appl Microbiol Biotechnol; 2013 May; 97(9):3885-92. PubMed ID: 23324803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Killing of non-replicating Mycobacterium tuberculosis by 8-hydroxyquinoline.
    Darby CM; Nathan CF
    J Antimicrob Chemother; 2010 Jul; 65(7):1424-7. PubMed ID: 20435781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Studies of the resistance of mycobacteria].
    Savov N
    Vet Med Nauki; 1973; 10(2):39-49. PubMed ID: 4213759
    [No Abstract]   [Full Text] [Related]  

  • 27. Brevianamides with antitubercular potential from a marine-derived isolate of Aspergillus versicolor.
    Song F; Liu X; Guo H; Ren B; Chen C; Piggott AM; Yu K; Gao H; Wang Q; Liu M; Liu X; Dai H; Zhang L; Capon RJ
    Org Lett; 2012 Sep; 14(18):4770-3. PubMed ID: 22963079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting dormant tuberculosis bacilli: results for molecules with a novel pyrimidone scaffold.
    Joshi RR; Barchha A; Khedkar VM; Pissurlenkar RR; Sarkar S; Sarkar D; Joshi RR; Joshi RA; Shah AK; Coutinho EC
    Chem Biol Drug Des; 2015 Feb; 85(2):201-7. PubMed ID: 24917467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Facile synthesis of 1,3-thiazolidin-4-ones as antitubercular agents.
    Subhedar DD; Shaikh MH; Arkile MA; Yeware A; Sarkar D; Shingate BB
    Bioorg Med Chem Lett; 2016 Apr; 26(7):1704-8. PubMed ID: 26927426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro susceptibility of Mycobacterium bovis against moxifloxacin.
    Weiss T; Schönfeld N; Bettermann G; Blum TG; Kollmeier J; Mauch H; Bauer TT; Rüssmann H
    Int J Tuberc Lung Dis; 2012 Nov; 16(11):1562. PubMed ID: 23044455
    [No Abstract]   [Full Text] [Related]  

  • 31. [Inhibition of bacterial adhesion of uropathogenic Escherichia coli strains by the urine of patients treated with nitroxoline].
    Karam D; Amgar A; Bourlioux P
    Pathol Biol (Paris); 1988 May; 36(5):452-5. PubMed ID: 3043342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity of DSA against anaerobically adapted Mycobacterium bovis BCG in vitro.
    Parrish NM; Ko CG; Dick JD
    Tuberculosis (Edinb); 2009 Jul; 89(4):325-7. PubMed ID: 19520609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of emetine hydrochloride on the growth of different mycobacteria strains].
    Schwartz E
    Zentralbl Bakteriol Orig; 1969 Dec; 212(1):115-25. PubMed ID: 4989350
    [No Abstract]   [Full Text] [Related]  

  • 34. Protective effect of beta-glucan against mycobacterium bovis, BCG infection in BALB/c mice.
    Hetland G; Løvik M; Wiker HG
    Scand J Immunol; 1998 Jun; 47(6):548-53. PubMed ID: 9652822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of the sensitivity of Pseudomonas aeruginosa cultures that synthesize melanin and other pigments to 12 antibiotics and 5-nitro-8-quinolinol].
    Rozhavin MA; Sologub VV
    Antibiotiki; 1979 Dec; 24(12):921-2. PubMed ID: 117745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo efficiency of targeted norfloxacin against persistent, isoniazid-insensitive, Mycobacterium bovis BCG present in the physiologically hypoxic mouse liver.
    Balazuc AM; Lagranderie M; Chavarot P; Pescher P; Roseeuw E; Schacht E; Domurado D; Marchal G
    Microbes Infect; 2005 Jun; 7(7-8):969-75. PubMed ID: 15994108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activity of rifapentine and its metabolite 25-O-desacetylrifapentine compared with rifampicin and rifabutin against Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis and M. bovis BCG.
    Rastogi N; Goh KS; Berchel M; Bryskier A
    J Antimicrob Chemother; 2000 Oct; 46(4):565-70. PubMed ID: 11020253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activity of nitroxoline against clinical isolates of Candida species.
    Hernández Molina JM; Llosá J; Ventosa A
    Mycoses; 1991; 34(7-8):323-5. PubMed ID: 1803236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice.
    Matsumoto M; Hashizume H; Tomishige T; Kawasaki M; Tsubouchi H; Sasaki H; Shimokawa Y; Komatsu M
    PLoS Med; 2006 Nov; 3(11):e466. PubMed ID: 17132069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quinolidene based monocarbonyl curcumin analogues as promising antimycobacterial agents: Synthesis and molecular docking study.
    Subhedar DD; Shaikh MH; Nawale L; Sarkar D; Khedkar VM; Shingate BB
    Bioorg Med Chem Lett; 2017 Feb; 27(4):922-928. PubMed ID: 28110868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.